Liver Involvement in Children with Alpha-1 Antitrypsin Deficiency: A Multicenter Study
2
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Purpose: Alpha-1 antitrypsin deficiency (A1ATD) in one of the most common genetic causes of liver disease in children. We aimed to analyze the clinical characteristics and outcomes of patients with A1ATD. Methods: This study included patients with A1ATD from five pediatric hepatology units. Demographics, clinical findings, genetics, and outcome of the patients were recorded (n=25). Results: Eight patients (32.0%) had homozygous PiZZ genotype while 17 (68.0%) had heterozygous genotype. Patients with PiZZ genotype had lower alpha-1 antitrypsin levels than patients with PiMZ genotype (37.6±7.7 mg/dL vs. 66.5±22.7 mg/dL, p=0.0001). Patients with PiZZ genotype were diagnosed earlier than patients with PiMZ genotype, but this was not significant (13±6.8 months vs. 23.7±30.1 months, p=0.192). Follow-up revealed the death of one patient (12.5%) with a homozygous mutation, and revealed that one patient had child A cirrhosis, five patients (62.5%) had chronic hepatitis, and one patient (12.5%) was asymptomatic. Nine of the 17 patients with a heterozygous mutation had chronic hepatitis (52.9%), two (11.7%) had child A cirrhosis, and six (35.2%) were asymptomatic. Overall, 18 (72%) of the 25 children had liver pathology in the long-term. Conclusion: Although prevalence is rare, patients with liver disorders should be checked for alpha-1 antitrypsin levels. Moreover, long-term follow-up is essential because most patients have a liver pathology.
Abstract
Purpose: Alpha-1 antitrypsin deficiency (A1ATD) in one of the most common genetic causes of liver disease in children. We aimed to analyze the clinical characteristics and outcomes of patients with A1ATD. Methods: This study included patients with A1ATD from five pediatric hepatology units. Demographics, clinical findings, genetics, and outcome of the patients were recorded (n=25). Results: Eight patients (32.0%) had homozygous PiZZ genotype while 17 (68.0%) had heterozygous genotype. Patients with PiZZ genotype had lower alpha-1 antitrypsin levels than patients with PiMZ genotype (37.6±7.7 mg/dL vs. 66.5±22.7 mg/dL, p=0.0001). Patients with PiZZ genotype were diagnosed earlier than patients with PiMZ genotype, but this was not significant (13±6.8 months vs. 23.7±30.1 months, p=0.192). Follow-up revealed the death of one patient (12.5%) with a homozygous mutation, and revealed that one patient had child A cirrhosis, five patients (62.5%) had chronic hepatitis, and one patient (12.5%) was asymptomatic. Nine of the 17 patients with a heterozygous mutation had chronic hepatitis (52.9%), two (11.7%) had child A cirrhosis, and six (35.2%) were asymptomatic. Overall, 18 (72%) of the 25 children had liver pathology in the long-term. Conclusion: Although prevalence is rare, patients with liver disorders should be checked for alpha-1 antitrypsin levels. Moreover, long-term follow-up is essential because most patients have a liver pathology.
참고문헌 (22)
- Duvoix A, "Molecular pathogenesis of alpha-1-antitrypsin deficiency", Rev Mal Respir, 31, pp.992~1002 (2014)
- Hunt JM, "Alpha 1 anti-trypsin : one protein, many functions", Curr Mol Med, 12, pp.827~835 (2012)
- Silva D, "Alpha-1-antitrypsin(SERPINA1)mutation spectrum : three novel variants and haplotype characterization of rare deficiency alleles identified in Portugal", Respir Med, 116, pp.8~18 (2016)
- Bals R, "Alpha-1-antitrypsin deficiency", Best Pract Res Clin Gastroenterol, 24, pp.629~633 (2010)
- Mitchell EL, "Liver disease in Alpha-1 antitrypsin deficiency : current approaches and future directions", Curr Pathobiol Rep, 5, pp.243~252 (2017)
- Fairbanks KD, "Liver disease in alpha 1-antitrypsin deficiency : a review", Am J Gastroenterol, 103, pp.2136~2141 (2008)
- Bakula A, "Liver transplantation in polish children with α(1)-antitrypsin deficiency : a single-center experience", Transplant Proc, 48, pp.3323~3327 (2016)
- Clark VC, "Liver transplantation in alpha-1 antitrypsin deficiency", Clin Liver Dis, 21, pp.355~365 (2017)
- Bals R, "Identification of individuals with alpha-1-antitrypsin deficiency by a targeted screening program", Respir Med, 101, pp.1708~1714 (2007)
- Sveger T, "Liver disease in alpha1-antitrypsin deficiency detected by screening of 200, 000 infants", N Engl J Med, 294, pp.1316~1321 (1976)
- Motamed F, "Low incidence of alpha-1-antitrypsin deficiency in Iranian patients with neonatal cholestasis", Turk J Gastroenterol, 26, pp.251~253 (2015)
- Aydogdu S, "Outcome of pediatric liver transplant recipients in Turkey : single center experience", Pediatr Transplant, 9, pp.723~728 (2005)
- Sarı S, "Infantile cholestatic liver diseases : retrospective analysis of 190 cases", Turk Arch Ped, 47, pp.167~173 (2012)
- "Growth Stages 1: Infancy and Early Childhood"[URL]
- Comba A, "Retrospective analysis of children with α-1 antitrypsin deficiency", Eur J Gastroenterol Hepatol, 30, pp.774~778 (2018)
- Sveger T, "The liver in adolescents with alpha 1-antitrypsin deficiency", Hepatology, 22, pp.514~517 (1995)
- van Hasselt PM, "Vitamin K deficiency bleeding in cholestatic infants with alpha-1-antitrypsin deficiency", Arch Dis Child Fetal Neonatal Ed, 94, pp.F456~60 (2009)
- Ekelund H, "Late haemorrhagic disease in Sweden 1987-89", Acta Paediatr Scand, 80, pp.966~968 (1991)
- Graham RP, "SERPINA1 full-gene sequencing identifies rare mutations not detected in targeted mutation analysis", J Mol Diagn, 17, pp.689~694 (2015)
- Massi G, "Pathogenesis and pathology of liver disease associated with alpha 1-antitrypsin deficiency", Chest (1996)
- Teckman JH, "Liver disease in alpha-1 antitrypsin deficiency : current understanding and future therapy", COPD, 10(Suppl 1), pp.35~43 (2013)
- Teckman JH, "Baseline analysis of a young α-1-antitrypsin deficiency liver disease cohort reveals frequent portal hypertension", J Pediatr Gastroenterol Nutr, 61, pp.94~101 (2015)